Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (511-520 of 927) with videos related to

Pageof 93
Sort By:
Diabetes Care|April 30, 2002
Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetesJ Wouter Jukema, Yves F C Smets, Johan W van der Pijl, et al.
Iscience|April 1, 2024
Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiationNathalie A Reilly, Friederike Sonnet, Koen F Dekkers, et al.
Pharmacogenetics and Genomics|April 13, 2006
Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1Jasper S Wijpkema, Paul L van Haelst, Pascalle S Monraats, et al.
The American Journal of Cardiology|September 26, 2013
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary interventionMatthijs A Velders, Helèn Boden, Sjoerd H Hofma, et al.
Clinical Science (London, England : 1979)|April 8, 2004
An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in menWillem R P Agema, Moniek P M de Maat, Aeilko H Zwinderman, et al.
European Heart Journal|January 6, 2010
Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery diseaseFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
JAMA|November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialStephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2016
Echocardiographic associates of atrial fibrillation in end-stage renal diseaseLiselotte C R Hensen, Victoria Delgado, Suzanne E van Wijngaarden, et al.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Non-Coding RNA|January 25, 2022
Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney DiseaseQiao Zhao, Sabine J L Nooren, Laurien E Zijlstra, et al.
Pageof 93

Showing results (511-520 of 927) with videos related to

Sort By:
Pageof 93
Diabetes Care|April 30, 2002
Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetesJ Wouter Jukema, Yves F C Smets, Johan W van der Pijl, et al.
Iscience|April 1, 2024
Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiationNathalie A Reilly, Friederike Sonnet, Koen F Dekkers, et al.
Pharmacogenetics and Genomics|April 13, 2006
Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1Jasper S Wijpkema, Paul L van Haelst, Pascalle S Monraats, et al.
The American Journal of Cardiology|September 26, 2013
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary interventionMatthijs A Velders, Helèn Boden, Sjoerd H Hofma, et al.
Clinical Science (London, England : 1979)|April 8, 2004
An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in menWillem R P Agema, Moniek P M de Maat, Aeilko H Zwinderman, et al.
European Heart Journal|January 6, 2010
Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery diseaseFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
JAMA|November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialStephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2016
Echocardiographic associates of atrial fibrillation in end-stage renal diseaseLiselotte C R Hensen, Victoria Delgado, Suzanne E van Wijngaarden, et al.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Non-Coding RNA|January 25, 2022
Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney DiseaseQiao Zhao, Sabine J L Nooren, Laurien E Zijlstra, et al.
Pageof 93